Cinacalcet and vascular calcifications induced by calcitriol [6]

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 551-552

  Monge, Matthieu ^a   Shahapuni, Irina ^a   Harbouche, Laïd ^a   Morinière, Philippe ^a   El Esper, Najeh ^a   Massy, Ziad ^a   Choukroun, Gabriel ^a   Fournier, Albert ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANGIOTENSIN 1 RECEPTOR; APOLIPOPROTEIN E; CALCITRIOL; CALCIUM CARBONATE; CALCIUM ION; CALCIUM PHOSPHATE; CINACALCET; DRUG VEHICLE; NPS 558; PHOSPHATE BINDING AGENT; UNCLASSIFIED DRUG; VITAMIN D;

BLOOD VESSEL CALCIFICATION; CALCIUM INTAKE; HUMAN; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPOCALCEMIA; LETTER; NONHUMAN; PRIORITY JOURNAL; RAT STRAIN; TREATMENT OUTCOME; UREMIA;

ANIMALS; CALCINOSIS; CALCITRIOL; NAPHTHALENES; RATS; TREATMENT FAILURE; VASCULAR DISEASES;

EID: 31544469478     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi200     Document Type: Letter

References (11)

1. Henley C, Collonton M, Carttly, Shatzen E, Towler D, Martin D. 1,25(OH) vitamin D but not cinacalcet treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1370-1377
2. Fox J, Lowe S, Petty B, Nemeth E. NPS R-568: A type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium. J Pharmacol Exp Ther 1999; 290: 473-479
3. Slatopolsky E, Bricker NS. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 1973; 4: 141-145
4. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
5. Mansour J, Benyahia M, Harbouche L, Presne C, Moriniere P, Fournier A. Calcimimetic AMG 073 at 50 and 100 mg per day. Kidney Int 2003; 64: 2324-2325
6. Porsti I, Fan M, Koobi P et al. High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure. Kidney Int 2004; 66: 2155-2166
7. Phan O, Ivanovski O, Nguyen-Khoa T et al. Sevelamer prevents accelerated atherosclerosis in apolipoprotein E deficient (apoE-/-) mice with chronic renal failure (CRF) Abstract 5. J Am Soc Nephrol 2004; 15: 275A (Poster FPO962)
8. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401
9. Fournier A, Said S, Ghazali A et al. The clinical significance of adynamic bone disease in uremia. In: Grunfeld JP ed., Advances in Nephrology Year-Book. St Louis: Mosby, 1997; 27: 131-166
10. KDOQI: National Kidney Foundation KDOQI (Kidney Disease Outcomes Quality Initiative). Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 [Suppl 13]: S1-S201
11. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80: 1678S-1688S